How to Apply for the KRM Ayurveda Limited IPO: Step-by-Step Investment Guide

     

    KRM Ayurveda Ltd. operates in the AYUSH healthcare segment through a network of hospitals, clinics, teleconsultation services, and the manufacture of Ayurvedic and herbal products. Incorporated in 2019, the company began with a focus on kidney-related treatments and has since expanded its scope to cover other health conditions, including lifestyle and chronic disorders. Its operations span physical healthcare facilities as well as remote consultation and product distribution channels. The company’s activities are centred on integrating traditional Ayurvedic practices with structured treatment processes. 

    Investors who wish to apply for the KRM Ayurveda IPO can do so through the application process prescribed for public issues in India. Applications may be submitted using the ASBA facility through a bank account linked to a demat account, either via net banking or through a registered intermediary. Eligible investors can also apply through online investment platforms that support IPO applications. Applicants are required to select the relevant category, enter the bid details as per the issue terms, and confirm the mandate for blocking funds. Once submitted, the application remains subject to allotment as per regulatory procedures and disclosed timelines.

    For more details, visit the KRM Ayurveda Limited IPO page.

    KRM Ayurveda Limited IPO Details and Objectives

    Details

    Information

    IPO Date

    January 19, 2026 to January 21, 2026

    Issue Size

    57,40,000 shares (agg. up to ₹77 Cr)

    Price Band

    ₹128 to ₹135 per share

    Lot Size

    1000 shares

    Listing At

    NSE, SME

    Purpose of the IPO

    • Capital Expenditure for Construction and Development of Telemedicine Operational Facilities

    • Purchase of CRM Software and Hardware Infrastructure

    • Human Resources

    • Repayment/Prepayment of loan

    • To meet the Working Capital requirements of the Company

    • General Corporate Purposes

    Timeline of KRM Ayurveda Limited IPO

    Event

    Date

    IPO Open Date

    Mon, Jan 19, 2026

    IPO Close Date

    Wed, Jan 21, 2026

    Tentative Allotment

    Thu, Jan 22, 2026

    Initiation of Refunds

    Fri, Jan 23, 2026

    Credit of Shares to Demat

    Fri, Jan 23, 2026

    Tentative Listing Date

    Tue, Jan 27, 2026

    Cut-off time for UPI mandate confirmation

    5 PM on Wed, Jan 21, 2026

    Pricing & Lot Size of KRM Ayurveda Limited IPO

    Price Band for the IPO

    •  ₹128 to ₹135 per share

    Minimum Lot Size and Application Details

    Application

    Lots

    Shares

    Amount

    Individual investors (Retail) (Min)

    2

    2,000

    ₹2,70,000

    Individual investors (Retail) (Max)

    2

    2,000

    ₹2,70,000

    S-HNI (Min)

    3

    3,000

    ₹4,05,000

    S-HNI (Max)

    7

    7,000

    ₹9,45,000

    B-HNI (Min)

    8

    8,000

    ₹10,80,000

    KRM Ayurveda Limited IPO Application Process

    The KRM Ayurveda Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

    Step 1: Login to Your Trading Platform

    Access your trading account using the broker's app or website.

    Step 2: Navigate to the IPO Section

    Go to the IPO section to view active IPO listings.

    Step 3: Select the Open IPO and Click Apply

    Locate KRM Ayurveda Limited IPO in the list of available IPOs and click the ‘Apply’ button.

    Step 4: Enter the Quantity of Shares You Wish to Apply For

    Specify the number of shares (lot size: 1000 shares) within the price band of ₹128 to ₹135 per share.

    Step 5: Provide Your UPI ID

    Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.

    Step 6: Confirm the Application

    Review your application details and confirm the UPI mandate before 5 PM on the last application day.

    Step 7: Complete the Process and Wait for Allotment

    Submit the application and monitor the allotment status to check if shares have been allocated to you.

    Shares Offered in KRM Ayurveda IPO

    The allocation of shares in the KRM Ayurveda IPO is structured across investor categories in line with applicable regulatory requirements. The issue provides defined reservations for qualified institutional buyers, non-institutional investors, and retail individual investors, with each category allotted a specified proportion of the net issue. This allocation framework outlines how the shares offered are distributed among different classes of investors.

    Investor Category

    Shares Offered

    QIB Shares Offered

    Not more than 50% of the Net Issue

    Retail Shares Offered

    Not less than 35% of the Net Issue

    NII Shares Offered

    Not less than 15% of the Net Issue

    This reservation structure reflects the categorisation and allocation approach disclosed for the issue, indicating the proportion of shares available to each investor segment.

    Financial Health and Performance

    Key Financial Metrics

    • Total Assets: Grew from ₹39.48 crore in FY23 to ₹66.79 crore as of March 2025.

    • Total income: Stood at ₹76.95 crore in FY25, as compared to ₹89.38 crore in FY23.

    • Profit After Tax (PAT): Stood at ₹12.10 crore for March 2025 as compared to ₹7.60 crore in FY23.

    • Net Worth: Recorded at ₹23.88 crore in FY25 in comparison to ₹8.37 crore in FY23.

    • Reserves and surplus: Stood at ₹23.73 crore in FY25, as compared to ₹8.22 crore in FY23.

    • EBITDA: Stood at ₹19.11 crore in March 2025 in comparison to ₹11.03 crore in FY23.

    Recent Performance and Growth Prospects

    • The company’s asset base has expanded over the review period, indicating a broader operational scale and increased balance sheet size.

    • Total income in the most recent period reflects a moderation compared to an earlier year, suggesting changes in revenue composition or business activity levels.

    • Profit after tax has shown an upward movement over time, reflecting an improvement in post-expense earnings during the period under review.

    • Net worth has strengthened compared to earlier years, supported by internal accruals and retained earnings.

    • Reserves and surplus have increased, indicating accumulation of profits within the business rather than distribution.

    • Operating performance, as reflected at the earnings-before-depreciation-and-tax level, has improved over the period, pointing to better operating outcomes.

    • Overall, recent performance reflects a phase of balance sheet expansion alongside changes in income trends, with internal financial strengthening contributing to the company’s current position.

    Investment Risks and Opportunities

    Potential Risks of Investing in the IPO

    • The company operates in the AYUSH healthcare segment, where demand patterns, regulatory frameworks, and patient preferences may vary across regions, which can influence operational consistency.

    • A portion of the business is dependent on specialised healthcare services and teleconsultation models, where execution challenges, compliance requirements, or operational integration issues may affect outcomes.

    Opportunities and Growth Potential

    • KRM Ayurveda Ltd. has an established presence across hospitals, clinics, product manufacturing, and teleconsultation services, which provides multiple channels for service delivery within the traditional healthcare ecosystem.

    • The stated use of IPO proceeds towards infrastructure development, technology systems, human resources, and working capital reflects a focus on strengthening existing operations and supporting organised business expansion.

    Key Performance Indicator (KPI)

    KPI

    Mar 31, 2025

    ROE

    67.86%

    ROCE

    43.33%

    Debt/Equity

    1.31

    RoNW

    67.86%

    PAT Margin

    15.80%

    EBITDA Margin

    24.96%

    Price to Book Value

    0.08

    KRM Ayurveda Limited IPO Registrar & Lead Managers

    Registrar

    Lead Manager(s)

    Skyline Financial Services Pvt.Ltd.

    NEXGEN Financial Solutions Pvt. Ltd.

    Company Address of KRM Ayurveda Limited

    KRM Ayurveda Ltd. A-16 G T Karnal road North West Delhi, New Delhi, 110033

    Phone: +91- 9289101700

    Email: compliance@krmayurveda.com

    Website: http://www.krmayurvedaindia.com/

    Conclusion

    KRM Ayurveda Ltd. operates in the AYUSH healthcare segment through hospitals, clinics, teleconsultation services, and Ayurvedic product manufacturing. Since its incorporation in 2019, the company has expanded its treatment scope beyond kidney-related care to include other chronic and lifestyle-related health conditions, supported by physical facilities and remote service channels.

    The IPO outlines the company’s business profile, issue structure, objectives, and application process in line with regulatory disclosures. Investors may apply through ASBA-enabled bank accounts or eligible online platforms, subject to the prescribed procedures and timelines. All applications remain subject to allotment as per applicable regulations and issue terms.

    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your KRM Ayurveda IPO allotment status.   

    Frequently Asked Questions

    Published Date : 17 Jan 2026

    Disclaimer :

    Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Our Secure Trading Platforms

    Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    9 lakh+ Users

    icon-with-text

    4.9 App Rating

    icon-with-text

    4 Languages

    icon-with-text

    ₹7,300 Cr+ MTF Book

    icon-with-text
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |